Most mucoepidermoid carcinoma will have a CRTC1-MAML2 or CRTC3-MAML2 fusion, and ETV6/NTRK3 is a common measured molecular alteration in secretory carcinomas (8, 9). Here, MAML2 is linked to mucoepidermoid carcinoma.